31203EGP
- Active ingredient
- luspatercept
- Strength
- 25mg
- Form
- vial
- Manufacturer
- bristol-myers squibb scientific office
- Route
- injection
Uses
Used for treatment of anemia in adults with transfusion-dependent beta thalassemia and selected lower-risk myelodysplastic syndromes.
Do not use if
No specific contraindications are established other than hypersensitivity to the product.
Side effects
Common adverse effects include fatigue, headache, musculoskeletal pain, diarrhea, and dizziness.
Warnings
Monitor for hypertension and thromboembolic events during treatment.
How it works
An erythroid maturation agent that enhances red blood cell production by modulating TGF-beta signaling pathways.
Storage
Store refrigerated at 2–8°C in the original carton. Do not freeze.